Pituitary tumors: pathophysiology, clinical manifestations and management

被引:125
作者
Arafah, BM
Nasrallah, MP
机构
[1] Univ Hosp Cleveland, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA
关键词
D O I
10.1677/erc.0.0080287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pituitary tumors are frequently encountered intracranial neoplasms. They present with a variety of clinical manifestations that include symptoms and signs of excessive hormone secretion by the tumor, signs of hormone deficits by the normal pituitary gland and others related to expansion of the tumor mass and the resulting compression of surrounding structures such as the optic chiasm and cranial nerves. Advances in molecular biology, immunocytochemical staining and imaging, and the introduction of new treatment options have improved our understanding of the natural history of these adenomas and their management. Available treatments include surgical, medical and radiation therapy. Although the primary treatment for each tumor type may vary, it is important to consider all available options and select the most applicable for that patient. The interaction of all members of management team, including the primary care provider, the endocrinologist and the neurosurgeon in selecting the treatment course can only improve therapeutic outcome. Regardless of the initial choice of treatment, follow-up of all patients should be maintained indefinitely. The managing physician should be familiar with the natural history and long-term complications of pituitary adenomas, and with the side effects of treatments given over the years.
引用
收藏
页码:287 / 305
页数:19
相关论文
共 92 条
  • [1] METASTATIC TUMORS TO THE PITUITARY
    AABERG, JM
    KAY, M
    STERNAU, L
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 119 (06) : 779 - 785
  • [2] Cabergoline in the treatment of acromegaly: A study in 64 patients
    Abs, R
    Verhelst, J
    Maiter, D
    Van Acker, K
    Nobels, F
    Coolens, JL
    Mahler, C
    Beckers, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) : 374 - 378
  • [3] A polymorphism in the growth hormone (GH)-releasing hormone (GHRH) receptor gene is associated with elevated response to GHRH by human pituitary somatotrophinomas in vitro
    Adams, EF
    Symowski, H
    Buchfelder, M
    Poyner, DR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (01) : 33 - 36
  • [4] CLINICALLY NONFUNCTIONING PITUITARY-TUMORS ARE MONOCLONAL IN ORIGIN
    ALEXANDER, JM
    BILLER, BMK
    BIKKAL, H
    ZERVAS, NT
    ARNOLD, A
    KLIBANSKI, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) : 336 - 340
  • [5] IMMEDIATE RECOVERY OF PITUITARY-FUNCTION AFTER TRANSSPHENOIDAL RESECTION OF PITUITARY MACROADENOMAS
    ARAFAH, BM
    KAILANI, SH
    NEKL, KE
    GOLD, RS
    SELMAN, WR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (02) : 348 - 354
  • [6] The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas
    Arafah, BM
    Prunty, D
    Ybarra, J
    Hlavin, ML
    Selman, WR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) : 1789 - 1793
  • [7] Pituitary tumor apoplexy: Pathophysiology, clinical manifestations, and management
    Arafah, BM
    Ybarra, J
    Tarr, RW
    Madhun, ZT
    Selman, WR
    [J]. JOURNAL OF INTENSIVE CARE MEDICINE, 1997, 12 (03) : 123 - 134
  • [8] ARAFAH BM, 1987, J LAB CLIN MED, V109, P346
  • [9] ARAFAH BM, 1985, CONNS CURRENT THERAP, P472
  • [10] ARAFAH BM, 1995, CONT NEUROSURG, V17, P1